Resistin: a new link between obesity and insulin resistance?
Antonio Vidal-Puig,
Stephen O'Rahilly,
Antonio Vidal-Puig
University of Cambridge, Departments of Medicine and Clinical Biochemistry, Cambridge, UK
Search for more papers by this authorStephen O'Rahilly
University of Cambridge, Departments of Medicine and Clinical Biochemistry, Cambridge, UK
Search for more papers by this authorAntonio Vidal-Puig,
Stephen O'Rahilly,
Antonio Vidal-Puig
University of Cambridge, Departments of Medicine and Clinical Biochemistry, Cambridge, UK
Search for more papers by this authorStephen O'Rahilly
University of Cambridge, Departments of Medicine and Clinical Biochemistry, Cambridge, UK
Search for more papers by this author Stephen O'Rahilly MD, Box 157, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Fax: 01223 330160; E-mail: [email protected]
No abstract is available for this article.
References
- Barroso, L., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J., Chatterjee, V.K., O'Rahilly, S. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402 880–883.
- Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., Evans, R.M. (2001) PPAR gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine, 7 48–52.
- Griffin, M.E., Marcucci, M.J., Cline, G.W., Bell, K., Barucci, X., Lee, D., Goodyear, L.L., Kraegen, E.W., White, M.F., Shulman, G.I. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes, 48 1270–1274.
- Holcomb 1.X., Kabakof F.R.C., Chan, B., Baker, T.W., Gumey, A., Henzel, W., Nelson, C., Lowman, H.B., Wright, B.D., Skelton, N.J., Frantz, G.D., Tumas, D.B., Peale, F.V., Shelton, D.L., Hebert, C.C. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO Journal, 19 4046–4055.
- Hotamisligil, G.S., Arner, R., Caro, J.R., Atkinson, R.L., Spiegelman, B.M. (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Journal of Clinical Investigation, 95 2409–2415.
- Hotarnisligil, G.S., Shargill, N.S., Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science, 259 87–91.
- Kelley, D.E. & Mandarino, L.L. (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes, 49 677–683.
- Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S.M., Rothman, D.L., Roden, M., Shulman, G.I. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia, 42 113–116.
- Montague, C.T., Prins, J.R., Sanders, L., Zhang, L.L., Sewter, C.Y., Digby, L.E., Byrne, C.D., O'Rahilly, S. (1998) Depot-related gene expression in human subcutaneous & omental adipocytes. Diabetes, 47 1384–1391.
- Ofei, E., Hurel, S., Newkirk, L., Sopwith, M., Taylor, R. (1996) Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes, 45 881–885.
- Peraldi, P., Xti, M., Spiegelman, B.M. (1997) Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. Journal of Clinical Investigation, 100 1863–1869.
- Perseghin, G., Scifo, P., De Cobefli, R., Pagliato, E., Battezzati, A., Arcelloni, G., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., Luzi, L. (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a IH-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes, 48 1600–1606.
- Sewter, C.P., Digby, L.E., Blows, F., O'Rahilly, S. (1999) Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. Journal of Endocrinology, 16 33–38.
- Spiegelman, B.M. (1997) Peroxisome proliferator-activated receptor gamma: a key regulator of adipogenesis and systemic insulin sensitivity. European Journal of Medical Research, 2 457–464.
- Steppan, C.M., Bailey, S.T., Bliat, S., Brown, E.L., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., Lazar, M.A. (2001a) The hormone resistin links obesity to diabetes. Nature, 409 307–312.
- Steppan, C.M., Brown, E.L., Wright, C.M., Bliat, S., Banerjee, R.R., Dai, C.Y., Enders, G.H., Silberg, D.G., Wen, X., Wu, G.D., Lazar, M.A. (2001b) A family of tissue-specific resistin-like molecules. Proceedings of the National Academy Science USA, 98 502–506.
- Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J. (19944) Positional cloning of the mouse obese gene and its human homologue. Nature, 372 425–432.
Citing Literature
